Sort
11,323 grants matching “glioblastoma”
Augmenting focused ultrasound-mediated drug delivery to brain tumors with vascular normalization
$399,294Richard J Price · University Of Virginia · R21 · FY2024 · CA
Activation and Regulation of the Understudied Kinome Using MIB/MS Technology
$399,282Gary L. Johnson · Univ Of North Carolina Chapel Hill · U01 · FY2014 · MH
Tumor Monorail Device for Serial Glioblastoma Biopsy
$399,217Sean Meehan · Exvade Bioscience, Inc. · R44 · FY2023 · CA
Targeting proton-sensing GPR68 as a ferroptosis-based therapy for glioblastoma
$399,214Charles Houston Williams · Proton Bio, Inc. · R43 · FY2024 · CA
Growth inhibition of brain tumors by cord blood stem cells
$399,179Jasti S Rao · University Of Illinois At Chicago · R01 · FY2009 · NS
Sub-component for Institution # 16-01848 Novel moleculary targeted therapy of GBM
$399,165Waldemar Debinski · Wake Forest University Health Sciences · P01 · FY2018 · CA
Regulation of CXCR4 by cognate and non-cognate ligands
$399,097Elias Lolis · Yale University · R01 · FY2011 · AI
BIOMOLECULAR ANALYSIS USING LIQUID CRYSTALS
$399,019Nicholas L Abbott · University Of Wisconsin-Madison · R01 · FY2011 · CA
Phase 2 Study of TH-302 for the Treatment of Glioblastoma
$399,013Andrew Jacob Brenner · University Of Texas Hlth Science Center · R01 · FY2015 · FD
Enhance Cancer Therapeutics with 3-in-1 CAR T Cells
$398,997Jianping Huang · Immunogenik, Inc. · R41 · FY2025 · CA
Vulnerabilities of MMR-deficient glioblastoma
$398,997Benjamin W. Purow · University Of Virginia · R01 · FY2023 · NS
Vulnerabilities of MMR-deficient glioblastoma
$398,997Benjamin W. Purow · University Of Virginia · R01 · FY2022 · NS
Vulnerabilities of MMR-deficient glioblastoma
$398,997Benjamin W. Purow · University Of Virginia · R01 · FY2025 · NS
Novel immunotherapeutic potential of DGKalpha inhibition for glioblastoma
$398,997Benjamin W. Purow · University Of Virginia · R01 · FY2023 · NS
Nanotherapeutic treatment of the invasive glioblastoma microenvironment
$398,967Graeme F Woodworth · University Of Maryland Baltimore · R01 · FY2023 · NS
Arming Oncolytic HSV Vectors to Induce Anti-GBM Immune Responses in Syngeneic Mice
$398,871Joseph C. Glorioso · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · CA
Phase 2 Study of TH-302 for the Treatment of Glioblastoma
$398,845Andrew Jacob Brenner · University Of Texas Hlth Science Center · R01 · FY2014 · FD
MOSAIC: Biospecimen Core
$398,820Kristin R Swanson · Mayo Clinic Arizona · U54 · FY2023 · CA
Endothelial plasticity in glioma vascularization and therapy resistance
$398,750Yi Fan · University Of Pennsylvania · R01 · FY2023 · NS
Endothelial plasticity in glioma vascularization and therapy resistance
$398,750Yi Fan · University Of Pennsylvania · R01 · FY2022 · NS
Proj. 3: Immunosuppressive circuits in T cells and other immune cells in GBM patients enrolled in clinical trials
$398,683Kai W Wucherpfennig · Brigham And Women'S Hospital · P01 · FY2020 · CA
Whole-brain Spectroscopy Guided Personalized Mapping of Transducer Arrays for Glioblastoma Patients Receiving Tumor Treating Fields
$398,588Suyash Mohan · University Of Pennsylvania · R01 · FY2021 · CA
Targeting Brain Tumor Stem Cells Through Novel Therapeutic Combinations
$398,549Jeremy N Rich · Cleveland Clinic Lerner Com-Cwru · R01 · FY2014 · CA
Imaging and Tissue Biomarkers in Patients with Newly Diagnosed GBM
$398,516Sarah J. Nelson · University Of California, San Francisco · R01 · FY2008 · CA
Regulation of Macrophage- and Microglia-mediated STING Signaling in Glioblastoma
$398,459Rongze Olivia Lu · University Of California, San Francisco · R01 · FY2022 · NS